Cargando…

Association of triglyceride levels and prostate cancer: a Mendelian randomization study

BACKGROUND: The association between triglyceride and prostate cancer (PCa) has been reported in observational studies. However, the causality from triglyceride on PCa remained unknown. METHOD: Two-sample Mendelian randomization (MR) was performed with triglyceride genome-wide association study (GWAS...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Shusheng, Hu, Xia, Fan, Yanpeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620626/
https://www.ncbi.nlm.nih.gov/pubmed/36316671
http://dx.doi.org/10.1186/s12894-022-01120-6
_version_ 1784821366090891264
author Zhu, Shusheng
Hu, Xia
Fan, Yanpeng
author_facet Zhu, Shusheng
Hu, Xia
Fan, Yanpeng
author_sort Zhu, Shusheng
collection PubMed
description BACKGROUND: The association between triglyceride and prostate cancer (PCa) has been reported in observational studies. However, the causality from triglyceride on PCa remained unknown. METHOD: Two-sample Mendelian randomization (MR) was performed with triglyceride genome-wide association study (GWAS) data from 177,861 individuals and GWAS summary statistics of PCa from 463,010 individuals. Then, 48 single nucleotide polymorphisms (SNPs) of triglyceride were used as instrumental variables (IVs) to conduct MR analysis on PCa. Inverse‐variance weighted (IVW), Weighted median, MR‐Egger regression, Simple mode and Weighted mode were used for MR analysis. To verify the sensitivity of the data, heterogeneity test, pleiotropy test and leave-one-out sensitivity test were performed. RESULTS: Association for an effect of triglyceride on PCa risk was found in IVW (odds ratio [OR]: 1.002, 95% confidence interval (CI): 1.000–1.004, p = 0.016). However, opposing results were observed using the weighted median (OR: 1.001, 95% CI: 0.999–1.003, p = 0.499) and MR‐Egger (OR: 0.999, 95% CI: 0.995–1.002, p = 0.401) approach. After MRPRESSO, the same result was obtained by using IVW method (OR: 1.002, 95% CI: 1.001–1.004, p = 0.004). CONCLUSIONS: The large MR analysis indicated that the potential causal effect of triglyceride on PCa. The odds of PCa would increase with high levels of triglyceride.
format Online
Article
Text
id pubmed-9620626
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96206262022-11-01 Association of triglyceride levels and prostate cancer: a Mendelian randomization study Zhu, Shusheng Hu, Xia Fan, Yanpeng BMC Urol Research BACKGROUND: The association between triglyceride and prostate cancer (PCa) has been reported in observational studies. However, the causality from triglyceride on PCa remained unknown. METHOD: Two-sample Mendelian randomization (MR) was performed with triglyceride genome-wide association study (GWAS) data from 177,861 individuals and GWAS summary statistics of PCa from 463,010 individuals. Then, 48 single nucleotide polymorphisms (SNPs) of triglyceride were used as instrumental variables (IVs) to conduct MR analysis on PCa. Inverse‐variance weighted (IVW), Weighted median, MR‐Egger regression, Simple mode and Weighted mode were used for MR analysis. To verify the sensitivity of the data, heterogeneity test, pleiotropy test and leave-one-out sensitivity test were performed. RESULTS: Association for an effect of triglyceride on PCa risk was found in IVW (odds ratio [OR]: 1.002, 95% confidence interval (CI): 1.000–1.004, p = 0.016). However, opposing results were observed using the weighted median (OR: 1.001, 95% CI: 0.999–1.003, p = 0.499) and MR‐Egger (OR: 0.999, 95% CI: 0.995–1.002, p = 0.401) approach. After MRPRESSO, the same result was obtained by using IVW method (OR: 1.002, 95% CI: 1.001–1.004, p = 0.004). CONCLUSIONS: The large MR analysis indicated that the potential causal effect of triglyceride on PCa. The odds of PCa would increase with high levels of triglyceride. BioMed Central 2022-10-31 /pmc/articles/PMC9620626/ /pubmed/36316671 http://dx.doi.org/10.1186/s12894-022-01120-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhu, Shusheng
Hu, Xia
Fan, Yanpeng
Association of triglyceride levels and prostate cancer: a Mendelian randomization study
title Association of triglyceride levels and prostate cancer: a Mendelian randomization study
title_full Association of triglyceride levels and prostate cancer: a Mendelian randomization study
title_fullStr Association of triglyceride levels and prostate cancer: a Mendelian randomization study
title_full_unstemmed Association of triglyceride levels and prostate cancer: a Mendelian randomization study
title_short Association of triglyceride levels and prostate cancer: a Mendelian randomization study
title_sort association of triglyceride levels and prostate cancer: a mendelian randomization study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620626/
https://www.ncbi.nlm.nih.gov/pubmed/36316671
http://dx.doi.org/10.1186/s12894-022-01120-6
work_keys_str_mv AT zhushusheng associationoftriglyceridelevelsandprostatecanceramendelianrandomizationstudy
AT huxia associationoftriglyceridelevelsandprostatecanceramendelianrandomizationstudy
AT fanyanpeng associationoftriglyceridelevelsandprostatecanceramendelianrandomizationstudy